Paper7105380
Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.
Hill BT and 1 other. Cancer Chemother Pharmacol, 1982. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities. Papers, record 7105380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7105380
- Cell line
- L5178Y VCRR1 paper
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.
- PubMed
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Lymphocytes | Major topic |
| Neoplasms, Experimental | Major topic |
| Vinblastine | Major topic |
| Vincristine | Major topic |
| Animals | |
| Cell Line | |
| Drug Resistance | |
| Mice | |
| Vindesine |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 986302 | The value of adriamycin in overcoming resistance to methotrexate in tissue culture. | Eur J Cancer (1965) | 1976 | https://conductscience.org/library/papers/986302 | PubMed |
| 2 | 412968 | Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate. | J Med Chem | 1978 | https://conductscience.org/library/papers/412968 | PubMed |
| 3 | 7454202 | The mode of action of Vinca alkaloids. | Oncology | 1980 | https://conductscience.org/library/papers/7454202 | PubMed |
| 4 | 287570 | An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/287570 | PubMed |
| 5 | 679195 | Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture. | Cancer Res | 1978 | https://conductscience.org/library/papers/679195 | PubMed |
| 6 | 6943380 | Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines. | J Natl Cancer Inst | 1981 | https://conductscience.org/library/papers/6943380 | PubMed |
| 7 | 281559 | Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/281559 | PubMed |
| 8 | 7375474 | Partial cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to 4'-demethylepipodophyllotoxin ethylidene-beta-D-glucoside. | Proc Soc Exp Biol Med | 1980 | https://conductscience.org/library/papers/7375474 | PubMed |
| 9 | 709548 | Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/709548 | PubMed |
| 10 | 1168475 | Uptake and binding of vincristine by murine leukemia cells. | Biochem Pharmacol | 1975 | https://conductscience.org/library/papers/1168475 | PubMed |
| 11 | 6947891 | Concepts for controlling drug-resistant tumor cells. | Eur J Cancer (1965) | 1980 | https://conductscience.org/library/papers/6947891 | PubMed |
| 13 | 7296754 | Experimental in vivo cross-resistance of vinca alkaloid drugs. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7296754 | PubMed |
| 14 | 144604 | Flow microfluorometric estimation of G1 and G2 chalone inhibition of the JB-1 tumour cell cycle in vitro. | Exp Cell Res | 1977 | https://conductscience.org/library/papers/144604 | PubMed |
| 15 | 6953266 | Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate. | J Natl Cancer Inst | 1982 | https://conductscience.org/library/papers/6953266 | PubMed |
| 16 | 1083340 | Methotrexate resistance and uptake of DDMP by L5178Y cells. Selective protection with folinic acid. | Eur J Cancer (1965) | 1975 | https://conductscience.org/library/papers/1083340 | PubMed |
| 17 | 5464247 | Altered glycosidase levels in drug-resistant mouse leukemias. | Mol Pharmacol | 1970 | https://conductscience.org/library/papers/5464247 | PubMed |
| 18 | 7448818 | Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/7448818 | PubMed |
| 19 | 455584 | Vindesine as a single agent in the treatment of advanced malignant melanoma. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/455584 | PubMed |
| 20 | 7438119 | Phase I and II studies of vindesine. | Cancer Treat Rev | 1980 | https://conductscience.org/library/papers/7438119 | PubMed |
| 21 | 7214365 | Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. | Cancer Res | 1981 | https://conductscience.org/library/papers/7214365 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9740539 | Vinflunine (20',20'-difluoro-3',4'-dihydrovinorelbine), a novel Vinca alkaloid, which participates in P-glycoprotein (Pgp)-mediated multidrug resistance in vivo and in vitro. | Invest New Drugs | 1998 | https://conductscience.org/library/papers/9740539 | PubMed |
| 7765329 | Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765329 | PubMed |
| 6090762 | Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung. | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6090762 | PubMed |
| 4006052 | Decreased retention of vinca alkaloids in chronic lymphatic leukemia cells from refractory patients. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/4006052 | PubMed |
| 3858013 | Identification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/3858013 | PubMed |
| 3621454 | Selective interactions of verapamil with anthraquinones in adriamycin-sensitive and -resistant murine and human tumour cell lines in vitro. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3621454 | PubMed |
| 3583643 | Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs. | Invest New Drugs | 1986 | https://conductscience.org/library/papers/3583643 | PubMed |
| 3390658 | Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine. | Br J Pharmacol | 1988 | https://conductscience.org/library/papers/3390658 | PubMed |
| 2924371 | Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2924371 | PubMed |
| 1657846 | Characterization of an etoposide-resistant human K562 cell line, K/eto. | Jpn J Cancer Res | 1991 | https://conductscience.org/library/papers/1657846 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7105380
GET https://conductscience.org/api/papers/v1/7105380/references?page=2